We are live on ! Find out more
GCL

Glazer Capital LLC Portfolio holdings

AUM $4.71B
1-Year Est. Return 81.93%
This Fund
S&P 500
This Quarter Est. Return
+4.3%
1 Year Est. Return
+81.93%
3 Year Est. Return
+319.13%
5 Year Est. Return
+526.52%
10 Year Est. Return
+4,797.43%
AUM
$3.86B
AUM Growth
-$1.59B
Cap. Flow
-$1.68B
Cap. Flow %
-43.43%
Top 10 Hldgs %
19.14%
Holding
821
New
112
Increased
267
Reduced
93
Closed
295
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
AACIU
476
DELISTED
Armada Acquisition Corp. I Unit
AACIU
$5K ﹤0.01%
+494
New +$4.95K
MURFU
477
DELISTED
Murphy Canyon Acquisition Corp. Unit
MURFU
$5K ﹤0.01%
500
HMACW
478
DELISTED
Hainan Manaslu Acquisition Corp. Warrant
HMACW
$5K ﹤0.01%
100,000
-60,000
-38% -$2.07K
ASCBU
479
DELISTED
A SPAC II Acquisition Corp. Unit
ASCBU
$4K ﹤0.01%
391
+131
+50% +$1.32K
ESM.U
480
DELISTED
ESM Acquisition Corporation Units, each consisting of one Class A ordinary share and one-third of one redeemable warrant
ESM.U
$4K ﹤0.01%
369
XFINU
481
DELISTED
ExcelFin Acquisition Corp Unit
XFINU
$3K ﹤0.01%
+300
New +$3.02K
ACAXU
482
DELISTED
Alset Capital Acquisition Corp Unit
ACAXU
$3K ﹤0.01%
273
AOGOU
483
DELISTED
Arogo Capital Acquisition Corp. Unit
AOGOU
$3K ﹤0.01%
312
LVACU
484
DELISTED
LAVA Medtech Acquisition Corp. Unit
LVACU
$3K ﹤0.01%
+300
New +$3.03K
PLMJU
485
DELISTED
Plum Acquisition Corp. III Unit
PLMJU
$2K ﹤0.01%
183
-12,060
-99% -$120K
EVE.U
486
DELISTED
EVe Mobility Acquisition Corp Units, each consisting of one Class A ordinary share and one-half of one redeemable warrant
EVE.U
$2K ﹤0.01%
166
LHC.U
487
DELISTED
Leo Holdings Corp. II Units, each consisting of one Class A ordinary share and one-quarter of one redeemable warrant
LHC.U
$2K ﹤0.01%
200
MPRAU
488
DELISTED
Mercato Partners Acquisition Corporation Unit
MPRAU
$2K ﹤0.01%
+200
New +$2.02K
FGMCU
489
DELISTED
FG Merger Corp. Unit
FGMCU
$2K ﹤0.01%
215
+200
+1,333% +$2.02K
QFTA.U
490
DELISTED
Quantum FinTech Acquisition Corporation Units, each consisting of one share of Common Stock and one Warrant
QFTA.U
$2K ﹤0.01%
+200
New +$1.98K
VLATU
491
DELISTED
Valor Latitude Acquisition Corp. Unit
VLATU
$2K ﹤0.01%
+202
New +$2.02K
IVCAU
492
DELISTED
Investcorp AI Acquisition Corp. Unit
IVCAU
$2K ﹤0.01%
+161
New +$1.64K
BMAC.U
493
DELISTED
Black Mountain Acquisition Corp. Units, each consisting of one share of Class A common stock and three quarters of one warrant
BMAC.U
$2K ﹤0.01%
+200
New +$2.02K
EVGRU
494
DELISTED
Evergreen Corporation Unit
EVGRU
$1K ﹤0.01%
67
BCSAU
495
DELISTED
Blockchain Coinvestors Acquisition Corp. I Unit
BCSAU
$1K ﹤0.01%
+109
New +$1.11K
PTWOU
496
DELISTED
Pono Capital Two, Inc. Unit
PTWOU
$1K ﹤0.01%
+100
New +$1.02K
GAMCU
497
DELISTED
Golden Arrow Merger Corp. Unit
GAMCU
$1K ﹤0.01%
100
-9,894
-99% -$98.7K
OCAXU
498
DELISTED
OCA Acquisition Corp. Unit
OCAXU
$1K ﹤0.01%
+100
New +$1.01K
SVNAU
499
DELISTED
7 Acquisition Corp Unit
SVNAU
$1K ﹤0.01%
102
+100
+5,000% +$1.02K
REVEU
500
DELISTED
Alpine Acquisition Corp Unit
REVEU
$1K ﹤0.01%
+69
New +$710

Similar funds

Glazer Capital LLC's Q4 2022 Portfolio in Review

As of Q4 2022, Glazer Capital LLC held 821 positions worth $3.86B, down 29% from $5.46B the previous quarter. Its ten largest holdings account for 19% of the portfolio.

Glazer Capital LLC withdrew a net $1.68B in Q4 2022, closing 295 positions and reducing 93 holdings. Its most notable exit was Biohaven Pharmaceutical Holding Company Ltd., an estimated $187M position sold in full.

By sector, the portfolio is most concentrated in Financials at 69% of assets, up from 64% a quarter earlier, followed by Technology and Industrials.

Against the trend, Glazer Capital LLC opened a new position in Horizon Therapeutics Public Limited Company Ordinary Shares worth $41M.

  • Glazer Capital LLC's largest Q4 2022 buy was Horizon Therapeutics Public Limited Company Ordinary Shares: 360,496 shares worth $41M.
  • Glazer Capital LLC added most to Jaws Mustang Acquisition Corp. in Q4 2022, an estimated $52.5M increase.
  • Glazer Capital LLC's biggest Q4 2022 reduction was Envoy Medical, cutting an estimated $34M.
  • Glazer Capital LLC fully exited Biohaven Pharmaceutical Holding Company Ltd. in Q4 2022, selling an estimated $187M.
  • Glazer Capital LLC's ten largest holdings make up 19% of its $3.86B portfolio in Q4 2022.
  • Glazer Capital LLC opened 112 new positions and closed 295 in Q4 2022.
  • Glazer Capital LLC's portfolio value fell 29% quarter-over-quarter to $3.86B.

Based on Glazer Capital LLC's 13F filing for Q4 2022, filed 14 Feb 2023.